2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Lymphomas: Brentuximab Vedotin vs. Pembrolizumab - Which Single Agent Should You Pick First for R/R cHL?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Neha Mehta-Shah
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Neha Mehta-Shah
Comments 0
Login to view comments.
Click here to Login
